Lv11
40 积分 2023-09-13 加入
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
2小时前
已完结
Growth differentiation factor 15: Emerging role in liver diseases
6天前
已完结
Novel mechanistic insights – A brand new Era for anti-HBV drugs
1个月前
已完结
慢性乙型肝炎抗病毒治疗新药研究进展
1个月前
已完结
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
1个月前
已完结
Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy
1个月前
已完结
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
2个月前
已完结
GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15 Caroline Chang
3个月前
已完结
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D
4个月前
已完结
皖公网安备34019202002308
